Literature DB >> 30266518

Defining antimicrobial resistance in cystic fibrosis.

Timothy J Kidd1, Rafael Canton2, Miquel Ekkelenkamp3, Helle Krogh Johansen4, Peter Gilligan5, John J LiPuma6, Scott C Bell7, J Stuart Elborn8, Patrick A Flume9, Donald R VanDevanter10, Valerie J Waters11.   

Abstract

Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.
Copyright © 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30266518     DOI： 10.1016/j.jcf.2018.08.014

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


  13 in total

1.  Liquid Chromatography Mass Spectrometry Detection of Antibiotic Agents in Sputum from Persons with Cystic Fibrosis.

Authors:  Tara Gallagher; Stefan Riedel; Joseph Kapcia; Lindsay J Caverly; Lisa Carmody; Linda M Kalikin; Junnan Lu; Joann Phan; Matthew Gargus; Miki Kagawa; Simon W Leemans; Jason A Rothman; Felix Grun; John J LiPuma; Katrine L Whiteson
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

2.  Clinical Impact of Aspergillus fumigatus in Children with Cystic Fibrosis.

Authors:  Valentina Fainardi; Chiara Sodini; Michela Deolmi; Andrea Ciuni; Kaltra Skenderaj; Maria Bice Stabile; Cosimo Neglia; Elena Mariotti Zani; Cinzia Spaggiari; Nicola Sverzellati; Susanna Esposito; Giovanna Pisi
Journal:  Microorganisms       Date:  2022-03-29

3.  Aerosol-based antimicrobial photoinactivation in the lungs: an action spectrum study.

Authors:  Chiara Treghini; Alfonso Dell'Accio; Franco Fusi; Giovanni Romano
Journal:  Photochem Photobiol Sci       Date:  2021-07-17       Impact factor: 3.982

Review 4.  Achromobacter Infections and Treatment Options.

Authors:  Burcu Isler; Timothy J Kidd; Adam G Stewart; Patrick Harris; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 5.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

Review 6.  Overcoming Challenges to Make Bacteriophage Therapy Standard Clinical Treatment Practice for Cystic Fibrosis.

Authors:  Renee N Ng; Anna S Tai; Barbara J Chang; Stephen M Stick; Anthony Kicic
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

7.  Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.

Authors:  Claire L Keating; Jonathan B Zuckerman; Pradeep K Singh; Matthew McKevitt; Oksana Gurtovaya; Mark Bresnik; Bruce C Marshall; Lisa Saiman
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

8.  Let-7b-5p in vesicles secreted by human airway cells reduces biofilm formation and increases antibiotic sensitivity of P. aeruginosa.

Authors:  Katja Koeppen; Amanda Nymon; Roxanna Barnaby; Laura Bashor; Zhongyou Li; Thomas H Hampton; Amanda E Liefeld; Fred W Kolling; Ian S LaCroix; Scott A Gerber; Deborah A Hogan; Swetha Kasetty; Carey D Nadell; Bruce A Stanton
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

Review 9.  Microbiology of Cystic Fibrosis Airway Disease.

Authors:  Ana C Blanchard; Valerie J Waters
Journal:  Semin Respir Crit Care Med       Date:  2019-12-30       Impact factor: 3.119

10.  A new BiofilmChip device for testing biofilm formation and antibiotic susceptibility.

Authors:  Núria Blanco-Cabra; Maria José López-Martínez; Betsy Verónica Arévalo-Jaimes; María Teresa Martin-Gómez; Josep Samitier; Eduard Torrents
Journal:  NPJ Biofilms Microbiomes       Date:  2021-08-03       Impact factor: 7.290
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.